These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22577228)

  • 1. A clinical and family history study of Parkinson's disease in heterozygous glucocerebrosidase mutation carriers.
    McNeill A; Duran R; Hughes DA; Mehta A; Schapira AH
    J Neurol Neurosurg Psychiatry; 2012 Aug; 83(8):853-4. PubMed ID: 22577228
    [No Abstract]   [Full Text] [Related]  

  • 2. Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells.
    McNeill A; Magalhaes J; Shen C; Chau KY; Hughes D; Mehta A; Foltynie T; Cooper JM; Abramov AY; Gegg M; Schapira AH
    Brain; 2014 May; 137(Pt 5):1481-95. PubMed ID: 24574503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid fatty acids in glucocerebrosidase-associated Parkinson's disease.
    Schmid SP; Schleicher ED; Cegan A; Deuschle C; Baur S; Hauser AK; Synofzik M; Srulijes K; Brockmann K; Berg D; Maetzler W
    Mov Disord; 2012 Feb; 27(2):288-92. PubMed ID: 22021190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. White matter abnormalities in Parkinson's disease patients with glucocerebrosidase gene mutations.
    Agosta F; Kostic VS; Davidovic K; Kresojević N; Sarro L; Svetel M; Stanković I; Comi G; Klein C; Filippi M
    Mov Disord; 2013 Jun; 28(6):772-8. PubMed ID: 23418083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocerebrosidase enzyme activity in GBA mutation Parkinson's disease.
    Ortega RA; Torres PA; Swan M; Nichols W; Boschung S; Raymond D; Barrett MJ; Johannes BA; Severt L; Shanker V; Hunt AL; Bressman S; Pastores GM; Saunders-Pullman R
    J Clin Neurosci; 2016 Jun; 28():185-6. PubMed ID: 26857292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkinson's disease in patients and obligate carriers of Gaucher disease.
    Becker JG; Pastores GM; Di Rocco A; Ferraris M; Graber JJ; Sathe S
    Parkinsonism Relat Disord; 2013 Jan; 19(1):129-31. PubMed ID: 22940477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive and motor functioning in elderly glucocerebrosidase mutation carriers.
    Moran EE; Wang C; Katz M; Ozelius L; Schwartz A; Pavlovic J; Ortega RA; Lipton RB; Zimmerman ME; Saunders-Pullman R
    Neurobiol Aging; 2017 Oct; 58():239.e1-239.e7. PubMed ID: 28728889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations.
    Alcalay RN; Levy OA; Waters CC; Fahn S; Ford B; Kuo SH; Mazzoni P; Pauciulo MW; Nichols WC; Gan-Or Z; Rouleau GA; Chung WK; Wolf P; Oliva P; Keutzer J; Marder K; Zhang X
    Brain; 2015 Sep; 138(Pt 9):2648-58. PubMed ID: 26117366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson's disease and the heterozygous state for glucocerebrosidase mutations among Brazilians.
    Socal MP; Bock H; Michelin-Tirelli K; Hilbig A; Saraiva-Pereira ML; Rieder CR; Jardim LB
    Parkinsonism Relat Disord; 2009 Jan; 15(1):76-8. PubMed ID: 18358758
    [No Abstract]   [Full Text] [Related]  

  • 10. Glucocerebrosidase mutations in a French-Canadian Parkinson's disease cohort.
    Noreau A; Rivière JB; Diab S; Dion PA; Panisset M; Soland V; Jodoin N; Langlois M; Chouinard S; Dupré N; Rouleau GA
    Can J Neurol Sci; 2011 Sep; 38(5):772-3. PubMed ID: 21856586
    [No Abstract]   [Full Text] [Related]  

  • 11. Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews.
    Aharon-Peretz J; Rosenbaum H; Gershoni-Baruch R
    N Engl J Med; 2004 Nov; 351(19):1972-7. PubMed ID: 15525722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease.
    Clark LN; Ross BM; Wang Y; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K
    Neurology; 2007 Sep; 69(12):1270-7. PubMed ID: 17875915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews.
    Eblan MJ; Walker JM; Sidransky E
    N Engl J Med; 2005 Feb; 352(7):728-31; author reply 728-31. PubMed ID: 15716572
    [No Abstract]   [Full Text] [Related]  

  • 14. Glucocerebrosidase gene mutations are associated with Parkinson's disease in southern Italy.
    De Marco EV; Annesi G; Tarantino P; Rocca FE; Provenzano G; Civitelli D; Cirò Candiano IC; Annesi F; Carrideo S; Condino F; Nicoletti G; Messina D; Novellino F; Morelli M; Quattrone A
    Mov Disord; 2008 Feb; 23(3):460-3. PubMed ID: 18074383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews.
    Zimran A; Neudorfer O; Elstein D
    N Engl J Med; 2005 Feb; 352(7):728-31; author reply 728-31. PubMed ID: 15719452
    [No Abstract]   [Full Text] [Related]  

  • 16. Glucocerebrosidase mutations influence the natural history of Parkinson's disease in a community-based incident cohort.
    Winder-Rhodes SE; Evans JR; Ban M; Mason SL; Williams-Gray CH; Foltynie T; Duran R; Mencacci NE; Sawcer SJ; Barker RA
    Brain; 2013 Feb; 136(Pt 2):392-9. PubMed ID: 23413260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocerebrosidase mutations do not cause increased Lewy body pathology in Parkinson's disease.
    Parkkinen L; Neumann J; O'Sullivan SS; Holton JL; Revesz T; Hardy J; Lees AJ
    Mol Genet Metab; 2011 Aug; 103(4):410-2. PubMed ID: 21621439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocerebrosidase gene mutations and Parkinson disease in the Norwegian population.
    Toft M; Pielsticker L; Ross OA; Aasly JO; Farrer MJ
    Neurology; 2006 Feb; 66(3):415-7. PubMed ID: 16476943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in glucocerebrosidase are a major genetic risk factor for Parkinson's disease and increase susceptibility to dementia in a Flanders-Belgian cohort.
    Crosiers D; Verstraeten A; Wauters E; Engelborghs S; Peeters K; Mattheijssens M; De Deyn PP; Theuns J; Van Broeckhoven C; Cras P
    Neurosci Lett; 2016 Aug; 629():160-164. PubMed ID: 27397011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutation.
    Fishbein I; Kuo YM; Giasson BI; Nussbaum RL
    Brain; 2014 Dec; 137(Pt 12):3235-47. PubMed ID: 25351739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.